**Background:** Closed claims are frequently used in outcomes research studies. Lately, the availability of open claims has increased the possibility of obtaining information faster and on a larger scale. However, because of the possibility of missing claims and duplications, these data sets have not been highly utilized in medical research. **Objective:** To compare frequently used healthcare utilization measures between closed claims and open claims to analyze if the possibility of missing claims in open claims data creates a downward bias in the estimates. **Methods:** We identified 18 different diseases using 2022 data from 2 closed claims data sets (MarketScan® and PharMetrics® Plus) and 1 open claims database (Kythera). After applyin...
Background: Access to unpublished clinical study reports (CSRs) is currently being discussed as a me...
Background: A promising approach to reduce the increasing costs of clinical trials is the use of ro...
Objectives: To demonstrate a threat to validity in using claims-based risk tools with chronically il...
Abstract: Claims data have become common during the past two decades. The electronic records include...
Purpose: Pharmacoepidemiology studies often use insurance claims and/or electronic health records (E...
Considerations for using administrative claims data in research have not been well-described. To inc...
Background: Health insurance claims data offer a unique opportunity to study disease distribution on...
BACKGROUND: Data collected as part of routine clinical practice could be used to detect cardiovascul...
analyze the medical large claims experience study (mlces) with r not a survey, not even remotely c...
Background The growing availability of electronic health records (EHRs) in the US could provide rese...
Background: To demonstrate that subject selection based on sufficient laboratory results and medicat...
<div><p>Background</p><p>Access to unpublished clinical study reports (CSRs) is currently being disc...
Pharmacoepidemiology studies often use insurance claims and electronic medical record (EMR) data. Ho...
In the decades prior to the introduction of electronic health records (EHRs), the best source of ele...
ObjectiveTo describe what information is or is not included in health care claims data, provide an o...
Background: Access to unpublished clinical study reports (CSRs) is currently being discussed as a me...
Background: A promising approach to reduce the increasing costs of clinical trials is the use of ro...
Objectives: To demonstrate a threat to validity in using claims-based risk tools with chronically il...
Abstract: Claims data have become common during the past two decades. The electronic records include...
Purpose: Pharmacoepidemiology studies often use insurance claims and/or electronic health records (E...
Considerations for using administrative claims data in research have not been well-described. To inc...
Background: Health insurance claims data offer a unique opportunity to study disease distribution on...
BACKGROUND: Data collected as part of routine clinical practice could be used to detect cardiovascul...
analyze the medical large claims experience study (mlces) with r not a survey, not even remotely c...
Background The growing availability of electronic health records (EHRs) in the US could provide rese...
Background: To demonstrate that subject selection based on sufficient laboratory results and medicat...
<div><p>Background</p><p>Access to unpublished clinical study reports (CSRs) is currently being disc...
Pharmacoepidemiology studies often use insurance claims and electronic medical record (EMR) data. Ho...
In the decades prior to the introduction of electronic health records (EHRs), the best source of ele...
ObjectiveTo describe what information is or is not included in health care claims data, provide an o...
Background: Access to unpublished clinical study reports (CSRs) is currently being discussed as a me...
Background: A promising approach to reduce the increasing costs of clinical trials is the use of ro...
Objectives: To demonstrate a threat to validity in using claims-based risk tools with chronically il...